Evidence map›Paper›PMID 35113901›Full record

ArticlePloS one2022

Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness.

Amiel A Dror, Nicole Morozov, Amani Daoud, Yoav Namir, Orly Yakir, Yair Shachar, Mark Lifshitz, Ella Segal, Lior Fisher, Matti Mizrachi and 8 more

Retracted Registry-linked trialOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. It is linked to trial NCT04810949 (Effect of Vitamin D Supplementation on the Development of Respiratory Infections), which is not on this map. Cited by 53 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 6 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04810949 naterminatednot on this map

Effect of Vitamin D Supplementation on the Development of Respiratory Infections (COVID-19) in Health Personnel at Hospital Clínica NOVA With Serum Values> 20ng / ml

TypeinterventionalSponsorHospital Clinica NovaRan2020 to 2021Enrolled41ConditionsCovid19, Influenza A, Influenza B, H1N1 InfluenzaArmsVitamine D3 supplementation, Diet and sun exposure
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 6 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. The potential role of 1,25(OH)Journal of inflammation (London, England) · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Amiel A DrorDepartment of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.ORCID 0000-0002-7178-6771
Nicole MorozovSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0001-6869-8626
Amani DaoudDepartment of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.
Yoav NamirAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Orly YakirStatistical Analysis Division, Galilee Medical Center, Nahariya, Israel.
Yair ShacharDepartment of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.
Mark LifshitzComputer Data Division, Galilee Medical Center, Nahariya, Israel.
Ella SegalDepartment of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.
Lior FisherDepartment of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.
Matti MizrachiDepartment of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.
Netanel EisenbachDepartment of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.
Doaa RayanDepartment of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.
Maayan GruberDepartment of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.
Amir BashkinAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Edward KaykovAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Masad BarhoumGalilee Medical Center, Nahariya, Israel.
Michael EdelsteinAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Eyal SelaDepartment of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.
Bar-Ilan University · ILWestern Galilee Hospital · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveStudies have demonstrated a potential correlation between low vitamin D status and both an increased risk of infection with SARS-CoV-2 and poorer clinical outcomes. This retrospective study examines if, and to what degree, a relationship exists between pre-infection serum 25-hydroxyvitamin D (25(OH)D) level and disease severity and mortality due to SARS-CoV-2.

participantsThe records of individuals admitted between April 7th, 2020 and February 4th, 2021 to the Galilee Medical Center (GMC) in Nahariya, Israel, with positive polymerase chain reaction (PCR) tests for SARS-CoV-2 (COVID-19) were searched for historical 25(OH)D levels measured 14 to 730 days prior to the positive PCR test.

designPatients admitted to GMC with COVID-19 were categorized according to disease severity and level of 25(OH)D. An association between pre-infection 25(OH)D levels, divided between four categories (deficient, insufficient, adequate, and high-normal), and COVID-19 severity was ascertained utilizing a multivariable regression analysis. To isolate the possible influence of the sinusoidal pattern of seasonal 25(OH)D changes throughout the year, a cosinor model was used.

resultsOf 1176 patients admitted, 253 had records of a 25(OH)D level prior to COVID-19 infection. A lower vitamin D status was more common in patients with the severe or critical disease (<20 ng/mL [87.4%]) than in individuals with mild or moderate disease (<20 ng/mL [34.3%] p < 0.001). Patients with vitamin D deficiency (<20 ng/mL) were 14 times more likely to have severe or critical disease than patients with 25(OH)D ≥40 ng/mL (odds ratio [OR], 14; 95% confidence interval [CI], 4 to 51; p < 0.001).

conclusionsAmong hospitalized COVID-19 patients, pre-infection deficiency of vitamin D was associated with increased disease severity and mortality.

Indexed as

Severity of Illness IndexAdultAgedAged, 80 and overComorbidityCOVID-19FemaleHumansIsraelMaleMiddle AgedPatient AdmissionPrognosisRetrospective StudiesRisk FactorsSARS-CoV-225-hydroxyvitamin DVitamin D

Identifiers

PMID35113901
PMCPMC8812897
OpenAlexW4225544452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.